↓ Skip to main content

Albendazole sensitizes cancer cells to ionizing radiation

Overview of attention for article published in Radiation Oncology, November 2011
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
56 Dimensions

Readers on

mendeley
49 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Albendazole sensitizes cancer cells to ionizing radiation
Published in
Radiation Oncology, November 2011
DOI 10.1186/1748-717x-6-160
Pubmed ID
Authors

Kirtesh Patel, Nicole A Doudican, Peter B Schiff, Seth J Orlow

Abstract

Brain metastases afflict approximately half of patients with metastatic melanoma (MM) and small cell lung cancer (SCLC) and represent the direct cause of death in 60 to 70% of those affected. Standard of care remains ineffective in both types of cancer with the challenge of overcoming the blood brain barrier (BBB) exacerbating the clinical problem. Our purpose is to determine and characterize the potential of albendazole (ABZ) as a cytotoxic and radiosensitizing agent against MM and SCLC cells.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 49 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 49 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 10 20%
Student > Bachelor 7 14%
Other 4 8%
Researcher 4 8%
Student > Ph. D. Student 4 8%
Other 8 16%
Unknown 12 24%
Readers by discipline Count As %
Agricultural and Biological Sciences 11 22%
Pharmacology, Toxicology and Pharmaceutical Science 7 14%
Medicine and Dentistry 7 14%
Biochemistry, Genetics and Molecular Biology 6 12%
Engineering 2 4%
Other 3 6%
Unknown 13 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 November 2011.
All research outputs
#18,300,116
of 22,656,971 outputs
Outputs from Radiation Oncology
#1,406
of 2,041 outputs
Outputs of similar age
#195,056
of 238,843 outputs
Outputs of similar age from Radiation Oncology
#22
of 30 outputs
Altmetric has tracked 22,656,971 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,041 research outputs from this source. They receive a mean Attention Score of 2.7. This one is in the 18th percentile – i.e., 18% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 238,843 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 9th percentile – i.e., 9% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 30 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.